Rybelsus and Wegovy are the same molecule at different jobs. Rybelsus is oral semaglutide for type 2 diabetes (daily, lower dose, with the 30-minute fasting rule). Wegovy is the weight-loss shot (weekly, 2.4mg, 14.9% average loss). Same food framework; very different ambitions.
| A | B | |
|---|---|---|
| Purpose | Type 2 diabetes | Weight loss |
| Dose | 3-14mg daily | 2.4mg weekly |
| Form | Daily pill, fasting rule | Weekly injection |
| Weight loss | Modest (diabetes trials) | 14.9% (STEP 1) |
| Food rules | Same framework + pill timing | Same framework |
The same judgment framework runs across this site — protein, fiber and how heavy a food sits on a slow stomach.
| Easy on both | Risky on both |
|---|---|
|
|
Wegovy by a wide margin — it is the weight-loss dose, at 14.9% average, versus Rybelsus' modest diabetes-trial weight effect. They are built for different purposes.
Yes — the pill must be taken on an empty stomach with minimal water, then nothing by mouth for 30 minutes. Food blunts the absorption.
No — they are the same drug; taking both would duplicate it. Which form is right is a provider decision.
This comparison presents published trial data (STEP, SURMOUNT, SCALE, OASIS 4) and FDA label information for reference. It is not medical advice and does not recommend any medication. Prescription decisions belong to you and your healthcare provider.